Financials
Financial year 2025
Apotheker Bart Peeters Klinisch Bioloog from Mortsel, company number BE0788356612, closed financial year 2025 with a result of € 169,205 after tax. For that financial year Apotheker Bart Peeters Klinisch Bioloog recorded a gross margin of € 222,791 and equity of € 2,000. Compared with financial year 2024, the result moved from € 106,282 to € 169,205. Profitable, and profit is growing. The buffer shrank hard: equity is 98 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 2, 2026.
€ 2,000
▼ 98% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 169,205
▲ 59% vs 2024
Profit after tax over the fiscal year.
€ 296,213
▲ 122% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 298,777 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 5,916
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -4,497 | € 37,270 | € 139,447 | € 222,791 | ▲ 60% |
| Profit after taxes | € -4,907 | € 28,197 | € 106,282 | € 169,205 | ▲ 59% |
| Equity | € -2,907 | € 25,290 | € 131,572 | € 2,000 | ▼ 98% |
| Total debts | € 21,854 | € 26,667 | € 12,882 | € 304,693 | ▲ € 291,812 |
| Cash | € 17,889 | € 29,944 | € 133,414 | € 296,213 | ▲ 122% |
| Retained profit | € -4,907 | € 23,290 | € 129,572 | € 0 | ▼ 100% |
| Dividend | € 0 | € 0 | € 0 | € 298,777 | |
| Bank debt | € 0 | € 0 | € 6,760 | € 0 | ▼ 100% |
| Balance sheet total | € 18,946 | € 51,957 | € 144,453 | € 306,693 | ▲ 112% |
Key figures of Apotheker Bart Peeters Klinisch Bioloog, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Apotheker Bart Peeters Klinisch Bioloog?
What happened at Apotheker Bart Peeters Klinisch Bioloog in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 169,205 (▲ 59% vs 2024). Source: NBB ↗
- New establishment in Mortsel. KBO
- Bart Peeters became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 4,907 loss in 2022 to € 169,205 profit in 2025.
Paid € 88,254 in corporate taxes since 2022.
Best year ever: 2025, with € 169,205 profit.
Paid out € 298,777 in dividends to the owners in total.
Management
Behind Apotheker Bart Peeters Klinisch Bioloog is Bart Peeters.
Directors
According to the 2025 annual accounts
Bart Peeters
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Osylei 26
2640 Mortsel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0788.356.612
- VAT number
- BE 0788.356.612
- Registered office
- Osylei 26, 2640 Mortsel
- Names & denominations
- Apotheker Bart Peeters Klinisch Bioloog · Apr. Bart Peeters Kl. Bioloog
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 July 2022
- Peppol
- Active · Active since 24 Nov 2023
- Activities · NACE
Activiteiten van medische beeldvorming en medische laboratoria
Activiteiten van medische laboratoria
Speur- en ontwikkelingswerk op biotechnologisch gebied